Benitec appoints RNAi specialist to head US advisory board
18 September, 2003 by Tanya HollisBrisbane gene silencing company Benitec (ASX:BLT) has appointed a specialist in DNA-directed RNA interference to chair its scientific advisory board in the United States.
Gribbles enters biotech with genomics coup
17 September, 2003 by Tanya HollisPathology giant Gribbles (ASX:GGL) has announced a new subsidiary dedicated to biotechnology, with its first project being the development of a pre-natal screening test to detect genetic and chromosomal abnormalities.
Protemix aims to take NZ bio to market
12 September, 2003 by Graeme O'NeillProf Garth Cooper, CEO of Auckland biopharmaceutical company Protemix Corp, aims to make his company the first New Zealand biotech to take a discovered compound all the way to market.
CogState ponders market options
01 September, 2003 by Melissa TrudingerUnlisted Melbourne company CogState is contemplating a float on the Australian Stock Exchange, according to CEO Dr Peter Bick.
AGT soars on gene link news
26 August, 2003 by Melissa TrudingerShares in AGT Biosciences (ASX:AGT) soared more than 72 per cent to close at AUD$0.62 on Monday after a new study showed one of its licensed target genes was strongly linked to the development of insulin resistance.
Roo genome and other projects off the ground after ARC grants
26 August, 2003 by Graeme O'NeillProf Jennifer Marshall Graves' long-awaited Kangaroo Genome Project is up and hopping after last week's federal government announcement of funding for six new Australian Research Council Centres.
AGT Biosciences chases new market
20 August, 2003 by Jeremy TorrBuoyed by the data from a recent research paper out of Cambridge University, gene discovery biotech AGT Biosciences has announced it has broadened its patent covering PARL (formerly gene AGT203) to cover cancer, aging and some other diseases.
APAF ups the discovery ante
19 August, 2003 by Jeremy TorrThe Australian Proteome Analysis Facility (APAF) has "dramatically increased its throughput capability" with the installation of a new Applied Biosystems 4700 Proteomics Discovery System.
2003 Eureka winners
13 August, 2003 by Susan WilliamsonThis year's Eureka prizes were awarded last night in their usual black and red finery at a dinner function at Fox studios in Sydney.
Intel chips into a new market
13 August, 2003 by Jeremy TorrIntel, chip maker to millions of personal computers across the world, is looking hard at the next emerging market -- biotech devices.
New bio-IT firm aims to sort out the rank and file
13 August, 2003 by Melissa TrudingerIt's one thing to design a system that can allow a library of 100,000 compounds to be screened against a protein structure in a day to assess each compound's structural compatibility with the target site. It's another to offer a way to score or rank the compounds according to the best-predicted fit.
New transgene delivery technique takes a traditional route
12 August, 2003 by Graeme O'NeillAn Italian-Australian research partnership has demonstrated a potentially revolutionary technique for producing transgenic animals, using nature's own time-tested vector for delivering genes to eggs: sperm.
UNE to offer bioinformatics course
29 July, 2003 by Jeremy TorrNSW's University of New England (UNE) is to offer a course in bioinformatics next year, in recognition of the increased importance of the field for both mathematicians and biologists.
SGI launch makes new bid for research community
28 July, 2003 by David BraueSupercomputer maker SGI is trying to extend its lifespan in the high-performance computing (HPC) market with the launch of the Onyx4 UltraVision, an upgraded flagship system it hopes will appeal to life sciences and other researchers keen to get ever more detail in the graphical representation of their data.
Proteome Systems, CSIRO team up in data mining
24 July, 2003 by Pete YoungTwo of the leading forces in Australian bioinformatics are pooling their expertise to build a new generation of protein expression data mining tools.
